Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is Weak Biotech Sentiment Dragging LSE:PRM Lower?

Proteome Sciences Plc(LSE:PRM) is a UK-based biotechnology company specialising in proteomics, the large-scale study of proteins. The company provides biomarker discovery, validation services, and analytical solutions to pharmaceutical and biotechnology clients. ItsBusinessmodel is closely tied to research funding, partnerships, and the commercialisation of scientific …

Ankur Sharma | 28 April 2026

4DMedical (ASX:4DX) Analysis: From Clinical Breakthrough to Commercial Scale

This article provides a general information overview of 4DMedical'sBusiness, the operating context of the global lung imaging and cardiopulmonary diagnostics sector, recent financial performance, strategic priorities, competitive position and key risks. It draws on the FY25 result released in late 2025 and selected sector …

Aditi Sarkar | 28 April 2026

Could Scancell Deliver Breakthrough Growth in the Coming Years?

Introduction: What Triggered the Rise in SCLP Stock?

Ankur Sharma | 28 April 2026

Can LSE:CRTX Recover in the Biotech Sector?

CRISM Therapeutics Corporation(LSE:CRTX) has declined in today’sTrading session, reflecting ongoing pressure on early-stage biotechnology and pharmaceutical development companies. As a firm focused on developing therapeutic treatments, LSE:CRTX operates in a highly speculative sector where valuation is driven largely by clinical progress and funding availability. …

Divya Sood | 28 April 2026

Is This Rally in GENF Stock Just Speculation or Real Opportunity?

Introduction: What Triggered the Rise in GENF Stock?

Ankur Sharma | 28 April 2026

Is Smith & Nephew Undervalued in the Global Medical Devices Sector?

Smith & Nephew(LSE:SN.) has long been a frustrating stock for investors who admire the underlying medical-devices industry but want exposure to its growth andMarginprofile. The company plays in some of the most attractive subsectors of the global devices market — orthopaedics, sports medicine and …

Ankur Sharma | 28 April 2026

Can Oxford BioDynamics Recover in the Epigenetics Diagnostics Space?

Introduction: What Triggered the Drop in OBD Stock?

Ankur Sharma | 27 April 2026

Is Investor Confidence Falling in UK Medical Device Stocks Like IHC?

Introduction: What Triggered the Drop in IHC Stock?

Ankur Sharma | 27 April 2026

Is Genincode Facing Slow Adoption in Healthcare Diagnostics?

Introduction: What Triggered the Drop in GENI Stock?

Ankur Sharma | 27 April 2026

Is Biotech Weakness Impacting PRTC Stock?

PureTech Health Plc(LSE:PRTC) has declined today, reflecting softer sentiment across the biotechnology and life sciencesInvestmentspace. Unlike traditional biotech firms, the company operates as a creator and backer of innovative healthcare businesses, with exposure to multiple pipelineAssets. However, such models are highly sensitive to investor …

Ankur Sharma | 27 April 2026

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions